While there was no clear link between BACE1-AS expression and the diseased state, patients with AD exhibited a higher BACE1-AS expression compared to those at the pre-AD stage, thus corroborating the likely potential role of BACE1-AS as an AD biomarker [77]. Here, BACE1 is linked to Alzheimer disease.